These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 27518323)
21. Pharmacokinetics and Skin Tolerability of Intracutaneous Zolmitriptan Delivery in Swine Using Adhesive Dermally Applied Microarray. Nguyen J; Lewis H; Queja A; Diep AN; Hochart G; Ameri M J Pharm Sci; 2018 Aug; 107(8):2192-2197. PubMed ID: 29772224 [TBL] [Abstract][Full Text] [Related]
22. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine. Chen Y; Liu Y; Xie J; Zheng Q; Yue P; Chen L; Hu P; Yang M Int J Nanomedicine; 2020; 15():10435-10451. PubMed ID: 33380794 [TBL] [Abstract][Full Text] [Related]
23. Distribution of zolmitriptan into the CNS in healthy volunteers: a positron emission tomography study. Wall A; Kågedal M; Bergström M; Jacobsson E; Nilsson D; Antoni G; Frändberg P; Gustavsson SA; Långström B; Yates R Drugs R D; 2005; 6(3):139-47. PubMed ID: 15869317 [TBL] [Abstract][Full Text] [Related]
24. Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and Application. Srinivas NR; Syed M J Pain Palliat Care Pharmacother; 2016; 30(1):13-24. PubMed ID: 26865407 [TBL] [Abstract][Full Text] [Related]
25. Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray. Kellerman DJ; Ameri M; Tepper SJ Pain Manag; 2017 Nov; 7(6):559-567. PubMed ID: 28741429 [TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of zolmitriptan submicron emulsion for rapid and effective nasal absorption in beagle dogs. Yu C; Gu P; Zhang W; Qi N; Cai C; He H; Tang X Drug Dev Ind Pharm; 2011 Dec; 37(12):1509-16. PubMed ID: 21671836 [TBL] [Abstract][Full Text] [Related]
27. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan. Subedi RK; Ryoo JP; Moon C; Choi HK Int J Pharm; 2011 Oct; 419(1-2):209-14. PubMed ID: 21843607 [TBL] [Abstract][Full Text] [Related]
28. Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design. Kumar A; Garg T; Sarma GS; Rath G; Goyal AK Eur J Pharm Sci; 2015 Apr; 70():140-51. PubMed ID: 25676136 [TBL] [Abstract][Full Text] [Related]
29. Assessment Of Spanlastic Vesicles Of Zolmitriptan For Treating Migraine In Rats. El-Nabarawy NA; Teaima MH; Helal DA Drug Des Devel Ther; 2019; 13():3929-3937. PubMed ID: 31819367 [TBL] [Abstract][Full Text] [Related]
30. [Experience with intranasal zolmitriptan in cluster headache]. Pascual J; Navarro A; Caminero AB; Jurado C Neurologia; 2006 Apr; 21(3):131-4. PubMed ID: 16575626 [TBL] [Abstract][Full Text] [Related]
31. Bioequivalence study of 2 orodispersible formulations of zolmitriptan 5 mg in healthy volunteers. Cánovas M; Canals M; Polonio F; Cabré F Arzneimittelforschung; 2012 Oct; 62(10):482-6. PubMed ID: 22918855 [TBL] [Abstract][Full Text] [Related]
32. Determination of zolmitriptan and its primary metabolite, n-desmethy-zolmitriptan, in rat plasma by LC-MS-MS. Liu J; Zhou X J Chromatogr Sci; 2013 Jan; 51(1):59-64. PubMed ID: 22722326 [TBL] [Abstract][Full Text] [Related]
33. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting. Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670 [TBL] [Abstract][Full Text] [Related]
34. Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation. Liu C; Fang L AAPS PharmSciTech; 2015 Dec; 16(6):1245-53. PubMed ID: 25771739 [TBL] [Abstract][Full Text] [Related]
35. Systematic evaluation of matrix effect and cross-talk-free method for simultaneous determination of zolmitriptan and N-desmethyl zolmitriptan in human plasma: a sensitive LC-MS/MS method validation and its application to a clinical pharmacokinetic study. Patel B; Suhagia BN; Jangid AG; Mistri HN; Desai N Biomed Chromatogr; 2016 Mar; 30(3):447-58. PubMed ID: 26189757 [TBL] [Abstract][Full Text] [Related]
36. Determination of zolmitriptan in human plasma by liquid chromatography-tandem mass spectrometry method: application to a pharmacokinetic study. Chen X; Liu D; Luan Y; Jin F; Zhong D J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):30-5. PubMed ID: 16413836 [TBL] [Abstract][Full Text] [Related]
37. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics. Wavikar P; Pai R; Vavia P J Pharm Sci; 2017 Dec; 106(12):3613-3622. PubMed ID: 28923321 [TBL] [Abstract][Full Text] [Related]
38. Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation. Bayrak Z; Tas C; Tasdemir U; Erol H; Ozkan CK; Savaser A; Ozkan Y Eur J Pharm Biopharm; 2011 Aug; 78(3):499-505. PubMed ID: 21352916 [TBL] [Abstract][Full Text] [Related]
40. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older. McKeage K Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]